Jaguar Health Statistics
Total Valuation
Jaguar Health has a market cap or net worth of $1.82 million. The enterprise value is $28.85 million.
Important Dates
The next estimated earnings date is Thursday, August 13, 2026, before market open.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Jaguar Health has 603,134 shares outstanding. The number of shares has increased by 1,474.87% in one year.
| Current Share Class | 603,134 |
| Shares Outstanding | 603,134 |
| Shares Change (YoY) | +1,474.87% |
| Shares Change (QoQ) | +240.66% |
| Owned by Insiders (%) | 4.40% |
| Owned by Institutions (%) | 3.43% |
| Float | 576,576 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.06 |
| Forward PS | 0.12 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.98 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.65
| Current Ratio | 0.65 |
| Quick Ratio | 0.24 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -31.03 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -35.86% |
| Return on Invested Capital (ROIC) | -45.75% |
| Return on Capital Employed (ROCE) | -410.18% |
| Weighted Average Cost of Capital (WACC) | 1.98% |
| Revenue Per Employee | $629,128 |
| Profits Per Employee | -$1.07M |
| Employee Count | 47 |
| Asset Turnover | 0.67 |
| Inventory Turnover | 0.48 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -97.05% in the last 52 weeks. The beta is -0.10, so Jaguar Health's price volatility has been lower than the market average.
| Beta (5Y) | -0.10 |
| 52-Week Price Change | -97.05% |
| 50-Day Moving Average | 5.07 |
| 200-Day Moving Average | 32.58 |
| Relative Strength Index (RSI) | 42.90 |
| Average Volume (20 Days) | 93,884 |
Short Selling Information
The latest short interest is 64,056, so 10.62% of the outstanding shares have been sold short.
| Short Interest | 64,056 |
| Short Previous Month | 67,479 |
| Short % of Shares Out | 10.62% |
| Short % of Float | 11.11% |
| Short Ratio (days to cover) | 0.42 |
Income Statement
In the last 12 months, Jaguar Health had revenue of $29.57 million and -$50.13 million in losses. Loss per share was -$262.29.
| Revenue | 29.57M |
| Gross Profit | 25.15M |
| Operating Income | -25.51M |
| Pretax Income | -34.68M |
| Net Income | -50.13M |
| EBITDA | -23.60M |
| EBIT | -25.51M |
| Loss Per Share | -$262.29 |
Full Income StatementBalance Sheet
The company has $7.28 million in cash and $34.31 million in debt, giving a net cash position of -$27.03 million or -$44.82 per share.
| Cash & Cash Equivalents | 7.28M |
| Total Debt | 34.31M |
| Net Cash | -27.03M |
| Net Cash Per Share | -$44.82 |
| Equity (Book Value) | -6.28M |
| Book Value Per Share | -38.11 |
| Working Capital | -11.01M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$7.54 million and capital expenditures -$41,000, giving a free cash flow of -$7.58 million.
| Operating Cash Flow | -7.54M |
| Capital Expenditures | -41,000 |
| Depreciation & Amortization | 1.91M |
| Net Borrowing | 3.05M |
| Free Cash Flow | -7.58M |
| FCF Per Share | -$12.57 |
Full Cash Flow StatementMargins
Gross margin is 85.06%, with operating and profit margins of -86.26% and -115.39%.
| Gross Margin | 85.06% |
| Operating Margin | -86.26% |
| Pretax Margin | -117.28% |
| Profit Margin | -115.39% |
| EBITDA Margin | -79.81% |
| EBIT Margin | -86.26% |
| FCF Margin | n/a |
Dividends & Yields
Jaguar Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1,474.87% |
| Shareholder Yield | -1,474.87% |
| Earnings Yield | -2,761.10% |
| FCF Yield | -417.70% |
Analyst Forecast
The average price target for Jaguar Health is $262.50, which is 8,620.93% higher than the current price. The consensus rating is "Buy".
| Price Target | $262.50 |
| Price Target Difference | 8,620.93% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (3Y) | 221.30% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on April 30, 2026. It was a reverse split with a ratio of 1:35.
| Last Split Date | Apr 30, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:35 |
Scores
Jaguar Health has an Altman Z-Score of -16.37 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -16.37 |
| Piotroski F-Score | 4 |